Target intelligence / Profile preview

DNA polymerase and DNA replication machinery (Replisome)

Target
Replisome
Molecular classification
Enzyme, Enzyme complex, DNA-binding protein
01

Overview

The DNA polymerase and DNA replication machinery, collectively known as the replisome, is a highly coordinated multi-protein assembly essential for the faithful duplication of genetic material prior to cell division (Nature Reviews Molecular Cell Biology: The replisome). This complex includes DNA polymerases (such as alpha, delta, and epsilon in eukaryotes), helicases, primases, and sliding clamps like PCNA, which work together to unwind the double helix and synthesize new DNA strands (Wikipedia: DNA polymerase). Because uncontrolled proliferation is a defining characteristic of cancer, components of the replication machinery are frequently targeted by chemotherapeutic agents, such as nucleoside analogs that disrupt DNA synthesis (NIH/NCBI: DNA replication as a target for anticancer drugs). Similarly, viral and bacterial DNA polymerases are primary targets for anti-infective drugs, which exploit structural differences between pathogen and host enzymes to achieve selectivity (PubChem: Cytarabine). Despite their therapeutic utility, drugs targeting the replication machinery often exhibit significant toxicity toward rapidly dividing healthy cells, particularly in the bone marrow and intestinal epithelium, leading to side effects like immunosuppression and mucositis.

Other names
DNA replication complexDNA-directed DNA polymerase complexReplication fork machineryDNA replication apparatus
02

Mechanism of action

Inhibition of DNA synthesis through competitive binding with natural deoxynucleoside triphosphates (dNTPs), leading to incorporation into the nascent DNA strand and subsequent chain termination or stalling of the replication fork (StatPearls: DNA Polymerase; NIH/NCBI: DNA replication as a target for anticancer drugs).

03

Biological functions

DNA replicationDNA repairCell cycle regulationGenome maintenance
04

Disease associations

CancerViral infectionBacterial infectionGenetic disorders
05

Safety considerations

Myelosuppression (anemia, neutropenia, thrombocytopenia)Gastrointestinal toxicity (mucositis)NephrotoxicityPotential mutagenicity and secondary malignancies
06

Interacting drugs

Cytarabine

9 more in the full profile.

07

Biomarkers

PCNA (Proliferating Cell Nuclear Antigen)Ki-67MCM2-7 (Minichromosome Maintenance complex)DNA polymerase epsilon expression

Beyond the preview

Go deeper on DNA polymerase and DNA replication machinery (Replisome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase and DNA replication machinery (Replisome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call